Code Snippets
curl "https://financialdata.net/api/v1/company-information?identifier=GILD&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/company-information?identifier=GILD&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/company-information?identifier=GILD&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"trading_symbol": "GILD",
"central_index_key": "0000882095",
"registrant_name": "GILEAD SCIENCES, INC.",
"isin_number": "US3755581036",
"lei_number": "549300WTZWR07K8MNV44",
"ein_number": "943047598",
"exchange": "Nasdaq",
"sic_code": "2836",
"sic_description": "Biological Products, (No Diagnostic Substances)",
"fiscal_year_end": "1231",
"state_of_incorporation": "DE",
"address_street": "333 LAKESIDE DR",
"address_city": "FOSTER CITY",
"address_state": "CA",
"address_zip_code": "94404",
"address_country": "UNITED STATES",
"address_country_code": "US",
"phone_number": "6505743000",
"mailing_address": "333 LAKESIDE DR, FOSTER CITY, CA, 94404",
"business_address": "333 LAKESIDE DR, FOSTER CITY, CA, 94404",
"former_name": "GILEAD SCIENCES INC",
"industry": "Pharmaceutics",
"founding_date": "1987-06-22",
"chief_executive_officer": "Daniel O'Day",
"number_of_employees": 17000,
"website": "http://gilead.com",
"market_cap": 103200000000.0,
"shares_issued": 1241000000,
"shares_outstanding": 1239955155,
"description": "Gilead Sciences, Inc. (/ˈɡɪliəd/) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy."
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol for a security, or the central index key (CIK). The latter is assigned to the entity by the United States Securities and Exchange Commission. (e.g., MSFT, 0000789019) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
This API endpoint provides basic information about the company, such as its LEI number, industry, contact information, and other key facts. The data covers a few thousand US and international companies.
Company Profile
GILEAD SCIENCES, INC.
NASDAQ: GILD- Market Cap:$103.20B
- ISIN:US3755581036
- Fiscal Year End:12/31
- CEO:Daniel O'Day
- Employees:17000
Gilead Sciences, Inc. (/ˈɡɪliəd/) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
GILD Datasets
GILD Stock QuotesGILD Stock PricesGILD Minute PricesGILD Key MetricsGILD Market CapGILD Employee CountGILD Executive CompensationGILD Income StatementsGILD Balance Sheet StatementsGILD Cash Flow StatementsGILD Insider TransactionsGILD Senate TradingGILD Institutional HoldingsGILD Analyst ConsensusGILD Earnings ReleasesGILD Stock SplitsGILD DividendsGILD Short Interest